622 Morel and Marchand
collected by filtration. The filtrate was purified by a
flash chromatography on Merck 60 silica gel. The
column was first eluted with CH2Cl2/CCl4 (2:1) to
recover the starting heterodiene 1 and remaining
parts of 7. Other products of Table 1 were iso-
lated with diethyl ether as eluent and recrystal-
lized from CH2Cl2/petroleum ether (compounds 8)
or diethyl ether/petroleum ether (compounds 9, un-
precise melting points).
The 2-mercaptobenzimidazole (9a) (0.68 g,
2 mmol) was alkylated by iodomethane (0.43 g,
3 mmol) in dry CH2Cl2 (20 ml) containing triethy-
lamine (0.4 g, 4 mmol). The mixture was stirred at
room temperature for 10 min, washed with H2O and
concentrated to yield the 2-(methylthio) derivative
(10a) as a viscous product (0.65 g, 1.8 mmol).
2-(Dimethylamino)-3-(4-methoxyphenyl)-thiazo-
lo[3,2-a]benzimidazole (8a). m.p. 126 C. 1H NMR
2.65 (s, 6H), 3.89 (s, 3H), 6.80–7.20 (m, 3H), 7.06
(d, 2H, J = 8.8 Hz), 7.47 (d, 2H, J = 8.8 Hz), 7.70 (d,
1H, J = 8 Hz). 13C NMR 46.4 (NCH3), 55.3 (OCH3),
111.5, 114.2, 118.7, 120.1, 120.6, 122.7, 130.4,
131.4, 147.2, 160.5 (arom. C), 124.2 (t, 3 J = 3 Hz,
C-3), 140.5 (m, C-2), 152.3 (s, C-9a). MS calcd. for
C18H17N3OS m/z 323.1092 [M]+, found 323.1086;
m/z (rel. int.): 323 (100), 267 (70), 224 (10). Anal.
calcd.: C, 66.87; H, 5.26; N, 13.00; S, 9.90. Found: C,
66.94; H, 5.20; N, 13.11; S, 10.13.
3-(4-Chlorophenyl)-2-(dimethylamino)-thiazolo
[3,2-a]benzimidazole (8b). m.p. 130 C dec. 1H NMR
2.65 (s, 6H), 6.85–7.30 (m, 3H), 7.51 (s, 4H), 7.79
(d, 1H, J = 8 Hz). 13C NMR 46.3 (NCH3), 111.3,
118.9, 120.4, 122.9, 127.0, 129.1, 130.2, 131.3, 135.6,
147.1 (arom. C), 123.1 (br, C-3), 141.6 (m, C-2), 152.3
(s, C-9a). Anal. calcd. for C17H14ClN3S: C, 62.29; H,
4.27; N, 12.82; S, 9.77. Found: C, 62.08; H, 4.18;
N, 12.65; S, 10.11.
2,3-Dihydro-5-(dimethylamino)-3-(2-isothiocya-
natophenyl)-4-(4-methoxyphenyl)-2-thioxothiazole
(7a). m.p. 185 C (CH2Cl2/petroleum ether). IR 2000
1
1
cm . H NMR 2.60 (s, 6H), 3.72 (s, 3H), 6.74 (d,
2H, J = 8.9 Hz), 7.09 (d, 2H, J = 8.9 Hz), 7.00–7.30
(m, 4H). 13C NMR 45.5 (NCH3), 55.1 (OCH3), 113.7,
121.4, 125.5, 127.5, 130.3, 130.6, 130.8, 131.5, 135.8,
159.7 (arom. C), 131.9 (t, 3 J = 3.4 Hz, C-4), 140.9
(s, NCS), 141.8 (m, C-5), 184.8 (s, C-2). Anal. calcd.
for C19H17N3OS3: C, 57.14; H, 4.26; N, 10.53. Found:
C, 56.81; H, 4.12; N, 10.39.
N-[(Dimethylcarbamoyl) (4-methoxyphenyl)me-
thyl]-2-mercaptobenzimidazole (9a). m.p. 120 C
1
1
dec. IR 1635 cm . H NMR 3.13 (s, 3H), 3.14 (s,
3H), 3.77 (s, 3H), 6.90 (m, 6H), 7.30 (d, 2H, J = 8.7
Hz), 7.60 (s, 1H), 11.60 (br, 1H). 13C NMR 35.3,
36.5 (NCH3), 54.3 (OCH3), 58.6 (dt, 1 J = 137 Hz, 3 J =
4.3 Hz, CH), 108.9, 111.9, 113.4, 121.5, 121.8, 124.2,
128.7, 129.5, 131.4, 158.8 (arom. C), 167.4 (m, CO),
167.4 (screened, C-2). MS calcd. for C18H19N3O2S
m/z 341.1198 [M]+, found 341.1179; m/z (rel. int.):
341 (20), 296 (100), 273 (10), 167 (90). Anal. calcd.:
C, 63.34; H, 5.57; N, 12.32; S, 9.38. Found: C, 63.21;
H, 5.52; N, 12.25; S, 9.56.
4-(4-Chlorophenyl)-2,3-dihydro-5-(dimethylamino)-
3-(2-isothiocyanatophenyl)-2-thioxothiazole (7b).
m.p. 189 C (CH2Cl2/petroleum ether). 1H NMR ␦
2.61 (s, 6H), 7.11 (d, 2H, J = 8.5Hz), 7.21 (d, 2H,
J = 8.5 Hz), 7.30 (m, 4H). 13C NMR 45.4 (NCH3),
125.7, 127.6, 127.7, 128.7, 130.5, 130.6, 130.8, 131.4,
135.0, 135.4 (arom. C), 130.5 (screened, C-4), 141.0
(s, NCS), 142.5 (m, C-5), 185.1 (s, C-2). Anal. calcd.
for C18H14ClN3S3: C, 53.53; H, 3.47; Cl, 8.79; N, 10.40;
S, 23.79. Found: C, 53.15; H, 3.37; Cl, 8.81; N, 10.30;
S, 23.88.
N-[(4-Chlorophenyl) (dimethylcarbamoyl) methyl]-
2-mercaptobenzimidazole (9b). m.p. 125 C dec. IR
1
1630 cm . 1H NMR 3.13 (s, 3H), 3.14 (s, 3H), 6.97
(m, 4H), 7.31 (m, 4H), 7.61 (s, 1H), 11.70 (br, 1H). 13
C
NMR 36.4, 37.6 (NCH3), 59.1 (d, 1 J = 137 Hz, CH),
110.1, 112.7, 122.8, 123.1, 129.2, 129.7, 130.5, 132.0,
134.7 (arom. C), 167.8 (m, CO), 168.5 (t, J = 4.6 Hz,
C-2). MS calcd. for C17H16ClN3O m/z 345.0703 [M]+,
found 345.0705; m/z (rel. int.): 345 (20), 300 (100),
273 (20), 271 (15), 168 (35).
2,3-Dihydro-5-(dimethylamino)-3-(2-isothiocya-
natophenyl)-4-(4-nitrophenyl)-2-thioxothiazole (7c).
1
m.p. 183 C (CH2Cl2/diethyl ether). IR 2005 cm .
1H NMR 2.64 (s, 6H), 7.10–7.45 (m, 6H), 8.09 (d,
2H, J = 8.9 Hz). 13C NMR
45.4 (NCH3), 123.5,
126.0, 127.9, 130.5, 130.8, 135.0, 135.6, 147.3 (arom.
3
N-[(Dimethylcarbamoyl) (4-nitrophenyl) methyl]-
C), 128.7 (t, J = 3.7 Hz, C-4), 141.2 (s, NCS), 144.0
1
2-mercaptobenzimidazole (9c). m.p. 180 C dec. H
(m, C-5), 185.2 (s, C-2). MS calcd. for C18H14N4O2S3
+
.
NMR 3.13 (s, 3H), 3.15 (s, 3H), 7.04 (m, 4H), 7.49
(d, 2H, J = 8.6 Hz), 7.67 (s, 1H), 8.19 (d, 2H, J = 8.6
Hz), 11.70 (br, 1H). 13C NMR 36.7, 37.7 (NCH3),
59.0 (dt, 1 J = 136 Hz, 3 J = 3.6 Hz, CH), 110.3, 112.2,
m/z 414.0279 [M] , found 414.0267; m/z (rel. int.):
414 (100), 356 (70), 310 (10), 282 (12). Anal. calcd.:
C, 52.17; H, 3.38; N, 13.52; S, 23.18. Found: C, 52.18;
H, 3.22; N, 13.42; S, 23.24.